Sabine R. de Wild

De-escalation of radiotherapy after primary chemotherapy in cT1–2N1 breast cancer (RAPCHEM; BOOG 2010–03): 5-year follow-up results of a Dutch, prospective, registry study

Sabine R. de Wild, Linda de Munck, Janine M. Simons et al. · The Lancet Oncology · 2022 · 77 citations · Full text

Medicine, Oncology, Radiation Oncology +9

MINImal vs. MAXimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Cancer: Protocol of a Dutch Multicenter Registry Study (MINIMAX)

Sabine R. de Wild, Janine M. Simons, Marie-Jeanne T. F. D. Vrancken Peeters et al. · Clinical Breast Cancer · 2021 · 36 citations · Full text

Medicine, Oncology, Surgery +16

De-escalation of axillary treatment in the event of a positive sentinel lymph node biopsy in cT1–2 N0 breast cancer treated with mastectomy: nationwide registry study (BOOG 2013-07)

Sabine R. de Wild, Lori M. van Roozendaal, Johannes H.W. de Wilt et al. · British journal of surgery · 2024 · 17 citations · Full text

Medicine, Oncology, Surgery +17

Prognostic effect of nodal status before and after neoadjuvant chemotherapy in breast cancer: a Dutch population-based study

Sabine R. de Wild, Linetta B. Koppert, Linda de Munck et al. · Breast Cancer Research and Treatment · 2023 · 10 citations · Full text

Medicine, Oncology, Breast Oncology +14